Back

Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction (STEMI) in early-hospital period

25 April 2024 (09:00 - 12:30)
Organised by: Logo
Congress Presentation Part of: Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke Pharmacotherapy Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Miss Ani Tavaratsyan

Yerevan (Armenia)

6 More presentations in this session

Presentation thumbnail
Discussants - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke
Presentation thumbnail
Differences in left atrial functionality between individuals with ischemic stroke and healthy controls: a comparative analysis
Doctor D. Maritsa (London, GB)
Abstract
Presentation thumbnail
The role of intracoronary physiology measurements and acetylcholine provocation testing in patients with INOCA. First data from Latvia
Doctor B. Vitola (Riga, LV)
Abstract Slides
Presentation thumbnail
Association between apelin-12 and N-terminal pro-brain natriuretic peptide depending no- reflow phenomenon in STEMI patients
Doctor X. Krasniqi (Pristina, XK)
Abstract Slides
Presentation thumbnail
How much protected? Assessment of cardiovascular risk factors in patients with previous cardiovascular events admitted for acute coronary syndrome.
Doctor R. Gregorio Antunes Coelho (Setubal, PT)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2 - Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

The Event

Event poster

ESC Preventive Cardiology 2024

25 April - 27 April 2024

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources